Soy Consumption and Obesity

Abstract

Obesity is now present worldwide, including China, India and developing countries. It now seems no longer acceptable to argue that obesity can simply be explained in terms of caloric consumption only using simple concept of energy in and energy out. There may be specific causes of altered metabolism that produce nutritional imbalances. Individual variation in response to food intake may also be considered. Specific substances in the food chain can influence meta-bolism towards an increase in fat deposits. Xenoestrogens have been suggested to have such an influence. Soy contains phytoestrogens plus phytates, protease inhibitors and other anti-nutrients which block or compromise the body’s uptake of essential vitamins and minerals. This may contribute to nutritional anomalies. We analyzed data from WHO and FAO for 167 countries. These contained percentage of obese individuals (BMI > 30 kg/m2), GDP, caloric consump-tion per capita, and sugar and soy consumption per capita. Regressions and partial correlations were used. Soy con-sumption correlates significantly with levels of obesity, irrespective of GDP and caloric intake. For instance, poor Latin America with soy consumption of 28.9 kg/person/year has more obesity (18.4%) than better off European Union (14.1%) consuming 16.1 kg/person/year of soy. Soy consumption seems to contribute approximately 10% - 21% to the worldwide variation in obesity, depending on the method of statistical analysis. The ubiquitous presence of unfermented soy products in mass produced foods seems to be an important contributor to the obesity epidemic

Meat consumption providing a surplus energy in modern diet contributes to obesity prevalence: an ecological analysis

“…This means that errors are reduced but some inaccuracies related to reporting quality may still be present in the data. Similar data from the same sources were recently used to analyse the relationships between nutrients and obesity [31,32] and diabetes [33][34][35] in a number of publications.…”

New perspectives on evolutionary medicine: the relevance of microevolution for human health and disease

“…Other examples might be the alterations in prevalence and the etiology of metabolic syndrome, and the introduction of biologically active substances (for example, xenoestrogens or endocrine disruptors) into the food chain [58]. Finally, even within short time periods disorders of unknown cause, such as Paget's disease, can show a notable yet etiologically enigmatic alteration in prevalence [59].…”

Lifelong exposure to dietary isoflavones reduces risk of obesity in ovariectomized Wistar rats

“…Despite from these numerous beneficial reports there are also concerns that ISOs, similar to other estrogenic compounds, promote fat accumulation and therefore consumption may be associated with an increased risk to develop obesity . These concerns are in part based on the evidence that during critical periods of development estrogenic chemicals can have stimulatory effects on the development of obesity .…”